Transcriptional signatures differentiate pathogen- and treatment-specific host responses in patients with bacterial bloodstream infections

By sjmartinez • November 25, 2023

Thaden JT, Ahn R, Ruffin F, Gjertson DW, Hoffmann A, Fowler VG Jr, Yeaman MR. Transcriptional signatures differentiate pathogen- and treatment-specific host responses in patients with bacterial bloodstream infections. J Infect Dis. 2023 Nov 24:jiad498. doi: 10.1093/infdis/jiad498. Epub ahead of print. PMID: 38001039.

Tags: bacteremia, Escherichia coli, Infectious Diseases, Klebsiella pneumoniae, Molecular Medicine, Publications, Staphylococcus aureus, transcriptome

Related Posts

Serum Levels of Aryl Hydrocarbon Receptor Plasma Agonist Activity Are Reduced in Patients With NMOSD and Correlate With Disease Activity

Tsaktanis T, Ammon L, Lößlein L, Peter A, Vandrey O, Naumann UJ, Behne M, Cook LJ, Levy M, Yeaman MR, Bennett JL, Rothhammer V; Guthy-Jackson[...]

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

Bhimraj A, Falck-Ytter Y, Baden LR, Bedimo R, Cawcutt K, Cheng VC, Chew KW, Chiotos K, Daar ES, Dzierba AL, Glidden DV, Hardy EJ, Johnson[...]

Clinical consequences of delaying implementation of long-acting antiretroviral therapy for people with HIV and persistent viremia in the US

Pei PP, Jones M, Hu R, Chen W, Sax PE, Pandya A, Gandhi M, Eron JJ, Currier JS, Wilkin TJ, Reddy KP, Qoshe L, Hyle[...]